GO:1904716 positive regulation of chaperone-mediated autophagy: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904716 describes any process that activates or increases the frequency, rate or extent of chaperone-mediated autophagy (CMA), a selective lysosomal degradation pathway.
• CMA is mechanistically distinct from macroautophagy and microautophagy because it directly translocates unfolded substrate proteins bearing a KFERQ-like motif across the lysosomal membrane via LAMP2A.
• Positive regulation of CMA is controlled by lysosomal mTORC2/PHLPP1/Akt signaling, which modulates LAMP2A stability and CMA activity.
• CMA upregulation supports cancer stem cell maintenance and papillary thyroid carcinoma progression, making it a context-dependent therapeutic target.
• CMA suppresses apoptosis by regulating the unfolded protein response in chronic obstructive pulmonary disease pathogenesis.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of CMA regulators in disease.
Description
Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation in which cytosolic substrate proteins are recognized by chaperones and delivered directly to the lysosomal membrane for translocation and degradation. The Gene Ontology term GO:1904716, positive regulation of chaperone-mediated autophagy, captures any biological process that activates or increases the frequency, rate or extent of CMA. This term is critical for researchers because CMA activity is dynamically tuned by nutrient status, stress, and signaling inputs, and its dysregulation is implicated in cancer, neurodegeneration, and inflammatory disease. Understanding the positive regulation of CMA requires identifying the molecular players that stabilize LAMP2A, enhance substrate targeting, or relieve inhibitory signals. Experimental evidence shows that lysosomal mTORC2/PHLPP1/Akt signaling directly regulates CMA, providing a mechanistic entry point for pharmacological and genetic intervention. Moreover, CMA upregulation has been linked to cancer stem cell maintenance and papillary thyroid carcinoma progression, underscoring its disease relevance. This article integrates authoritative QuickGO annotation with verified PubMed literature to provide a research-grade overview of GO:1904716, its regulatory mechanisms, key genes, disease connections, and CRISPR-based research strategies.
positive regulation of chaperone-mediated autophagy At A Glance
| GO ID | GO:1904716 |
|---|---|
| GO term | positive regulation of chaperone-mediated autophagy |
| Ontology | biological_process |
| Synonym | activation of chaperone-mediated autophagy; activation of CMA; positive regulation of CMA; up regulation of chaperone-mediated autophagy; upregulation of CMA |
| Major function | Increases the frequency, rate or extent of chaperone-mediated autophagy, a selective lysosomal degradation pathway for KFERQ-motif-containing proteins |
| Key regulator | Lysosomal mTORC2/PHLPP1/Akt signaling modulates CMA activity |
| Disease relevance | Cancer stem cell maintenance, papillary thyroid carcinoma progression, COPD pathogenesis, and inflammatory myopathies |
| Experimental models | CRISPR knockout, point mutation, knock-in, and overexpression cell models; CMA flux assays |
What Is GO:1904716?
GO:1904716 (positive regulation of chaperone-mediated autophagy) is a biological process term defined as any process that activates or increases the frequency, rate or extent of chaperone-mediated autophagy. In practice, this includes signaling events that stabilize the lysosomal receptor LAMP2A, enhance substrate recognition by HSC70, promote lysosomal translocation, or increase lysosomal degradation capacity. The term is distinct from the core CMA process itself because it specifically describes positive regulatory inputs, such as kinase cascades, transcriptional programs, or protein-protein interactions that amplify CMA flux.
Why Is positive regulation of chaperone-mediated autophagy Important in Cell Biology?
Positive regulation of chaperone-mediated autophagy is important because CMA activity determines the clearance of specific cytosolic proteins that control cell survival, metabolism, and stress responses. Unlike bulk macroautophagy, CMA selectively degrades proteins with KFERQ-like motifs, and its upregulation can either protect cells or promote disease depending on context. For example, CMA suppresses apoptosis via regulation of the unfolded protein response in chronic obstructive pulmonary disease pathogenesis, while CMA upregulation supports cancer stem cell maintenance and papillary thyroid carcinoma progression. Therefore, understanding the positive regulation of CMA is essential for developing targeted therapies that modulate this pathway in cancer, neurodegeneration, and inflammatory diseases.
• CMA is a selective lysosomal degradation pathway distinct from macroautophagy, and its positive regulation controls the clearance of KFERQ-motif proteins.
• Lysosomal mTORC2/PHLPP1/Akt signaling directly regulates CMA, linking nutrient sensing to protein degradation.
• CMA upregulation supports cancer stem cell maintenance, making it a potential target in oncology.
• CMA governs papillary thyroid carcinoma progression via PPARγ-SDF1/CXCR4 signaling.
• CMA suppresses apoptosis by regulating the unfolded protein response in COPD pathogenesis.
• African swine fever virus hijacks CMA-induced lipolysis to upregulate fatty acid β-oxidation and promote viral replication.
• Anti-Ku myositis is an acquired inflammatory protein-aggregate myopathy that may involve CMA dysfunction.
• Creatine kinase B suppresses ferroptosis by phosphorylating GPX4, a process that may intersect with CMA regulation.
• CMA activity declines with age, contributing to neurodegeneration and protein aggregation diseases.
• CRISPR-based models enable causal dissection of CMA regulatory genes in human disease contexts.
What Happens During positive regulation of chaperone-mediated autophagy?
Substrate Recognition and Chaperone Targeting
In simple terms: Proteins destined for degradation are tagged and delivered to the lysosome.
In CMA, cytosolic substrate proteins containing a KFERQ-like motif are recognized by the chaperone HSC70 (HSPA8). This recognition step is the first committed step in CMA and is subject to positive regulation by co-chaperones and accessory proteins that enhance substrate unfolding and delivery to the lysosomal membrane. The positive regulation of CMA at this stage can occur through increased expression or activity of HSC70, or through modulation of co-chaperones that facilitate substrate transfer.
LAMP2A Stabilization and Lysosomal Docking
In simple terms: The lysosomal receptor LAMP2A must be stabilized to receive substrates.
LAMP2A is the lysosomal membrane receptor that binds CMA substrates and facilitates their translocation. Positive regulation of CMA frequently involves stabilization of LAMP2A at the lysosomal membrane, which can occur through changes in its oligomerization state or through interactions with lysosomal membrane proteins. The lysosomal mTORC2/PHLPP1/Akt signaling axis regulates CMA by modulating LAMP2A stability and function. This step is rate-limiting for CMA flux and is a major target for positive regulation.
Substrate Translocation and Degradation
In simple terms: The tagged protein is unfolded and threaded into the lysosome for destruction.
Once docked, the substrate protein is unfolded and translocated across the lysosomal membrane through a multimeric LAMP2A complex, a process that requires lysosomal HSC70 (lys-HSC70). Positive regulation of CMA can enhance translocation efficiency by increasing the availability of lys-HSC70 or by promoting the assembly of the translocation complex. After translocation, the substrate is rapidly degraded by lysosomal proteases, completing the CMA cycle.
Signaling Inputs That Amplify CMA
In simple terms: Cellular signals can turn up the volume on CMA.
Positive regulation of CMA is controlled by nutrient and stress signaling pathways. The lysosomal mTORC2/PHLPP1/Akt pathway is a key regulator: inhibition of mTORC2 or activation of PHLPP1 can enhance CMA activity. Additionally, oxidative stress and prolonged starvation are known to upregulate CMA as a survival mechanism. These signaling inputs converge on LAMP2A stability and HSC70 availability to increase CMA flux.
Transcriptional and Post-Translational Control
In simple terms: Cells can make more CMA components or modify them to boost activity.
Positive regulation of CMA can occur at the transcriptional level, where increased expression of LAMP2A or HSC70 elevates CMA capacity. Post-translational modifications, such as phosphorylation of LAMP2A or its regulators, also modulate CMA activity. For example, the mTORC2/PHLPP1/Akt axis controls LAMP2A phosphorylation status, thereby influencing CMA. These layers of regulation ensure that CMA is finely tuned to cellular demands.
Key Genes Involved in GO:1904716 positive regulation of chaperone-mediated autophagy
The following genes and proteins are central to the positive regulation of chaperone-mediated autophagy, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LAMP2A | Lysosomal receptor for CMA substrates; rate-limiting for CMA flux | Knockout and knock-in models to study CMA dependence in cancer and neurodegeneration |
| HSPA8 (HSC70) | Cytosolic chaperone that recognizes KFERQ motifs and delivers substrates to LAMP2A | Overexpression and point-mutation models to dissect substrate targeting |
| MTOR | Component of mTORC2 that regulates CMA via Akt signaling | Knockout and point-mutation models to study nutrient sensing |
| PHLPP1 | Phosphatase that inhibits Akt and positively regulates CMA | Overexpression models to enhance CMA activity |
| AKT1 | Kinase inhibited by PHLPP1; its inhibition promotes CMA | Point-mutation models to study signaling crosstalk |
| PPARG | Nuclear receptor linked to CMA regulation in papillary thyroid carcinoma | Knockout models to study CMA-driven tumor progression |
| CXCR4 | Chemokine receptor downstream of PPARγ-SDF1 signaling in CMA-dependent cancer | Knock-in and overexpression models for metastasis studies |
| GPX4 | Ferroptosis suppressor phosphorylated by CKB; may intersect with CMA | Point-mutation models to study oxidative stress and CMA |
| CKB | Creatine kinase B that phosphorylates GPX4 and suppresses ferroptosis | Knockout models to study CMA-ferroptosis crosstalk |
| HSP90AA1 | Chaperone that may assist in CMA substrate handling | Overexpression and knockout models for CMA flux |
| STUB1 | E3 ubiquitin ligase that may regulate CMA components | Knockout models to study post-translational regulation |
| BAG3 | Co-chaperone involved in protein quality control and CMA crosstalk | Knock-in models for stress response studies |
| TFEB | Transcription factor that may regulate lysosomal and CMA gene expression | Overexpression models to boost CMA capacity |
| SQSTM1 | Autophagy receptor that may influence CMA selectivity | Knockout models to study pathway crosstalk |
| MAP1LC3B | Macroautophagy marker with potential crosstalk to CMA | Knockout models to distinguish CMA from macroautophagy |
| RPS6KB1 | mTORC1 substrate that may indirectly affect CMA via nutrient signaling | Point-mutation models for signaling studies |
How Is positive regulation of chaperone-mediated autophagy Regulated?
Positive regulation of chaperone-mediated autophagy is primarily controlled by the lysosomal mTORC2/PHLPP1/Akt signaling axis. mTORC2 phosphorylates Akt to inhibit CMA, while PHLPP1 dephosphorylates Akt to relieve inhibition and enhance CMA. Nutrient availability, oxidative stress, and prolonged starvation are upstream inputs that modulate this axis. Additionally, transcriptional programs involving TFEB and other lysosomal biogenesis factors can increase CMA capacity by upregulating LAMP2A and HSC70 expression. Post-translational modifications of LAMP2A, including phosphorylation and oligomerization, provide rapid tuning of CMA activity. Together, these regulatory layers ensure that CMA is activated when cells require enhanced protein quality control or amino acid recycling.
positive regulation of chaperone-mediated autophagy and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LAMP2A | Cancer stem cell maintenance; papillary thyroid carcinoma | Knockout and overexpression cell models; CMA flux assays |
| PPARG | Papillary thyroid carcinoma progression via SDF1/CXCR4 | Knockout and point-mutation models in thyroid cancer cell lines |
| CXCR4 | Metastasis and chemokine signaling in CMA-dependent cancer | Knock-in and overexpression models for migration assays |
| GPX4 | Ferroptosis suppression and oxidative stress | Point-mutation models to study CMA-ferroptosis crosstalk |
| CKB | Ferroptosis regulation via GPX4 phosphorylation | Knockout models to assess CMA intersection |
Cancer Progression and Stem Cell Maintenance
Positive regulation of CMA supports cancer stem cell maintenance and tumor progression. In papillary thyroid carcinoma, CMA governs progression via PPARγ-SDF1/CXCR4 signaling, where upregulated CMA promotes cell migration and invasion. These findings suggest that inhibiting CMA could be a therapeutic strategy in cancers that depend on CMA for survival.
Chronic Obstructive Pulmonary Disease (COPD)
CMA suppresses apoptosis via regulation of the unfolded protein response during COPD pathogenesis. Positive regulation of CMA in this context may protect lung epithelial cells from stress-induced apoptosis, but excessive CMA could also contribute to tissue remodeling. Understanding the balance of CMA activity is critical for therapeutic targeting in COPD.
Inflammatory Myopathies and Protein Aggregation
Anti-Ku myositis is an acquired inflammatory protein-aggregate myopathy that may involve impaired CMA-mediated clearance of aggregated proteins. Positive regulation of CMA could potentially alleviate protein aggregate accumulation, but this hypothesis requires further investigation.
Viral Infection and Metabolic Reprogramming
African swine fever virus hijacks CMA-induced lipolysis to upregulate fatty acid β-oxidation and promote viral replication. This demonstrates that positive regulation of CMA can be co-opted by pathogens for their own benefit, highlighting the need for context-specific modulation.
From positive regulation of chaperone-mediated autophagy-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does LAMP2A loss abolish CMA and affect cancer stem cell maintenance? | LAMP2A knockout cell lines |
| Does PHLPP1 overexpression enhance CMA via Akt inhibition? | PHLPP1 overexpression and Akt point-mutation models |
| Does PPARγ-SDF1/CXCR4 signaling require CMA for thyroid cancer progression? | PPARG knockout and CXCR4 knock-in models |
| Does CKB-mediated GPX4 phosphorylation intersect with CMA regulation? | CKB knockout and GPX4 point-mutation models |
| Can TFEB overexpression boost CMA capacity? | TFEB overexpression models with CMA flux readouts |
| Does HSC70 substrate recognition require specific co-chaperones? | HSPA8 point-mutation and knockout models |
How to Study the positive regulation of chaperone-mediated autophagy Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CMA flux reporter assay | Selective degradation of KFERQ-motif proteins | Quantify positive regulation of CMA in live cells |
| Co-immunoprecipitation | Protein-protein interactions of LAMP2A and HSC70 | Identify CMA regulatory complexes |
| RNA-seq | Transcriptional changes driving CMA upregulation | Discover TFEB targets and signaling pathways |
| Proteomics | Global protein degradation and substrate identification | Map CMA substrate repertoire |
| Fluorescence microscopy | Lysosomal localization and translocation events | Visualize CMA activation |
| CRISPR knockout screening | Causal genes required for CMA upregulation | Identify positive regulators of CMA |
| Phosphoproteomics | Signaling changes in mTORC2/PHLPP1/Akt axis | Dissect CMA regulatory phosphorylation |
| Lysosomal isolation | LAMP2A levels and oligomerization state | Biochemical analysis of CMA machinery |
CMA Flux Assays
CMA activity is typically measured using photoactivatable or fluorescently tagged KFERQ-motif reporter proteins that are selectively degraded by CMA. These assays allow quantification of CMA flux in live cells and can be combined with CRISPR knockout of candidate regulators to establish causality.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify CMA substrates and interactors of LAMP2A and HSC70. Proximity labeling or co-immunoprecipitation followed by mass spectrometry can reveal dynamic changes in the CMA machinery under positive regulatory conditions.
Transcriptomics and RNA-seq
RNA sequencing can identify transcriptional programs that positively regulate CMA, such as TFEB target genes. Comparing wild-type and CRISPR knockout cells under CMA-inducing conditions reveals gene expression changes that drive or accompany CMA upregulation.
Imaging and Lysosomal Tracking
Fluorescence microscopy with lysosomal markers (e.g., LAMP1, LAMP2A) and pH-sensitive dyes can visualize CMA translocation events and lysosomal activity. Live-cell imaging of KFERQ reporters enables real-time monitoring of positive regulation of CMA.
How CRISPR Can Be Used to Study GO:1904716 positive regulation of chaperone-mediated autophagy
Knockout
CRISPR knockout of candidate positive regulators such as LAMP2A, MTOR, or PHLPP1 can determine whether they are required for CMA upregulation. Knockout cell models are essential for establishing causality and for identifying synthetic lethal interactions in cancer cells that depend on CMA.
Point Mutation
Point mutations in LAMP2A phosphorylation sites or in Akt kinase domains can dissect signaling events that positively regulate CMA. These models allow precise testing of phosphorylation-dependent regulation without confounding effects of protein loss.
Knock-in
Knock-in of tagged LAMP2A or HSC70 enables live-cell imaging and biochemical tracking of CMA components. Knock-in models can also introduce disease-associated mutations to study their impact on CMA regulation.
Overexpression
Overexpression of PHLPP1, TFEB, or HSC70 can enhance CMA activity and is useful for gain-of-function studies. Overexpression models help identify downstream consequences of CMA upregulation in cancer, neurodegeneration, and metabolic disease.
How EDITGENE Supports positive regulation of chaperone-mediated autophagy Research
Researchers studying positive regulation of chaperone-mediated autophagy-related genes often need to determine whether a candidate gene is causally involved in CMA activation or merely correlated with it. CRISPR-based genetic models provide the gold-standard approach for establishing causality, and EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of chaperone-mediated autophagy research.
Frequently Asked Questions About positive regulation of chaperone-mediated autophagy
What is GO:1904716 positive regulation of chaperone-mediated autophagy?
GO:1904716 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of chaperone-mediated autophagy, a selective lysosomal degradation pathway.
What genes are involved in positive regulation of chaperone-mediated autophagy?
Key genes include LAMP2A, HSPA8 (HSC70), MTOR, PHLPP1, AKT1, PPARG, and CXCR4, among others.
How is chaperone-mediated autophagy regulated?
CMA is regulated by lysosomal mTORC2/PHLPP1/Akt signaling, nutrient status, oxidative stress, and transcriptional programs involving TFEB.
What diseases are linked to chaperone-mediated autophagy?
CMA is linked to cancer stem cell maintenance, papillary thyroid carcinoma, COPD, inflammatory myopathies, and viral infections.
How can I study positive regulation of CMA using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can establish causal roles of candidate genes in CMA regulation.
What is the role of LAMP2A in CMA?
LAMP2A is the lysosomal receptor that binds CMA substrates and facilitates their translocation; its stabilization is a key step in positive regulation of CMA.
Does mTOR regulate chaperone-mediated autophagy?
Yes, lysosomal mTORC2 regulates CMA via Akt signaling, and inhibition of mTORC2 can enhance CMA activity.
What is the difference between CMA and macroautophagy?
CMA selectively degrades KFERQ-motif proteins directly via LAMP2A, while macroautophagy engulfs cytoplasmic cargo in autophagosomes.
Can CMA be targeted for cancer therapy?
CMA upregulation supports cancer stem cell maintenance and thyroid cancer progression, suggesting that CMA inhibition may be therapeutic in some cancers.
What methods measure CMA activity?
CMA flux reporter assays, proteomics, RNA-seq, fluorescence microscopy, and lysosomal isolation are commonly used to measure CMA activity.
Conclusion
GO:1904716 positive regulation of chaperone-mediated autophagy is a critical biological process that controls selective lysosomal degradation of KFERQ-motif proteins. Its regulation by mTORC2/PHLPP1/Akt signaling and its roles in cancer, COPD, and viral infection make it a high-priority research area. CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential tools for dissecting the causal roles of CMA regulators in human disease. EDITGENE provides comprehensive services to accelerate this research and translate findings into therapeutic strategies.
References
- 1. Yao R et al.. 2023. Chaperone-mediated autophagy: Molecular mechanisms, biological functions, and diseases.. MedComm (2020) 4(5):e347 PMID: 37655052
- 2. Wu K et al.. 2023. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function.. Nat Cell Biol 25(5):714-725 PMID: 37156912
- 3. Hosaka Y et al.. 2020. Chaperone-Mediated Autophagy Suppresses Apoptosis via Regulation of the Unfolded Protein Response during Chronic Obstructive Pulmonary Disease Pathogenesis.. J Immunol 205(5):1256-1267 PMID: 32699159
- 4. Yang X et al.. 2026. African swine fever virus hijacks lipolysis induced by chaperone-mediated autophagy to upregulate fatty acid β-oxidation and promote viral replication.. mBio 17(4):e0336825 PMID: 41801037
- 5. Auzmendi-Iriarte J et al.. 2022. Intrinsic role of chaperone-mediated autophagy in cancer stem cell maintenance.. Autophagy 18(12):3035-3036 PMID: 35468038
- 6. Holzer MT et al.. 2024. Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy.. Acta Neuropathol 148(1):6 PMID: 39012547
- 7. Arias E et al.. 2015. Lysosomal mTORC2/PHLPP1/Akt Regulate Chaperone-Mediated Autophagy.. Mol Cell 59(2):270-84 PMID: 26118642
- 8. Zhou H et al.. 2020. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.. J Clin Endocrinol Metab 105(10) PMID: 32556197
